Mutual Funds
Filters
Insights
Viewing 17 of 17
The importance of focus
Why focus and patience are crucial elements when investing and identifying growth companies.
Why growth, why now?
Tough times play to our strengths: analysing what enables us to adapt and thrive amid rapid change
Kweichow Moutai: spirit of China
The fiery spirit that’s a profitable symbol of Chinese culture and luxury.
China: the new shoots of growth
Why advanced manufacturing and social context are key to investing in tomorrow’s Chinese giants.
AI: driving a new healthcare paradigm
Why AI could be key to us living longer and being in better health in the future.
Why small companies matter to us
Unlocking the potential of small cap investments.
Thirty years of emerging markets
Baillie Gifford’s Will Sutcliffe explains how emerging markets have evolved in the last three decades.
Tilting the odds in your favour
The Magnificent Seven’s reputation goes before them but that’s not enough to save them.
Lessons from evolutionary biology
How the study of gene fitness can help us spot ambitious growth companies with huge potential.
The AI paradigm shift
Being open-minded to what rapid changes brought on by AI could mean for growth stocks.
Niches, anomalies, and things to come
How can we spot large growth opportunities at the stage when others dismiss them as fads?
Lessons in Morale
Challenges of the past year, the importance of maintaining an optimistic approach, and the continued belief in the long-term growth prospects of the companies in the International Growth portfolio.
Emerging Markets Fund – 2023 Reflections
Insights and Reflections from Baillie Gifford’s Emerging Markets Fund.
Baillie Gifford International Growth Fund – 2023 Reflections
'Unlocking International Growth Potential: Insights and Reflections from the Baillie Gifford International Growth Fund
International All Cap – 2023 Reflections
Insights and reflections from Baillie Gifford’s International All Cap strategy.
International All Cap Stewardship Report 2022
For the year ended June 2022.
The health revolution
What do Grail, Verve and Denali have in common? The ability to turn biology into information science and put it to revolutionary use transforming our health and wellbeing.
Recent insights
The importance of focus
Why focus and patience are crucial elements when investing and identifying growth companies.Why growth, why now?
Tough times play to our strengths: analysing what enables us to adapt and thrive amid rapid changeKweichow Moutai: spirit of China
The fiery spirit that’s a profitable symbol of Chinese culture and luxury.China: the new shoots of growth
Why advanced manufacturing and social context are key to investing in tomorrow’s Chinese giants.AI: driving a new healthcare paradigm
Why AI could be key to us living longer and being in better health in the future.Why small companies matter to us
Unlocking the potential of small cap investments.Thirty years of emerging markets
Baillie Gifford’s Will Sutcliffe explains how emerging markets have evolved in the last three decades.Tilting the odds in your favour
The Magnificent Seven’s reputation goes before them but that’s not enough to save them.Lessons from evolutionary biology
How the study of gene fitness can help us spot ambitious growth companies with huge potential.The AI paradigm shift
Being open-minded to what rapid changes brought on by AI could mean for growth stocks.Niches, anomalies, and things to come
How can we spot large growth opportunities at the stage when others dismiss them as fads?Lessons in Morale
Challenges of the past year, the importance of maintaining an optimistic approach, and the continued belief in the long-term growth prospects of the companies in the International Growth portfolio.Emerging Markets Fund – 2023 Reflections
Insights and Reflections from Baillie Gifford’s Emerging Markets Fund.Baillie Gifford International Growth Fund – 2023 Reflections
'Unlocking International Growth Potential: Insights and Reflections from the Baillie Gifford International Growth FundInternational All Cap – 2023 Reflections
Insights and reflections from Baillie Gifford’s International All Cap strategy.International All Cap Stewardship Report 2022
For the year ended June 2022.The health revolution
What do Grail, Verve and Denali have in common? The ability to turn biology into information science and put it to revolutionary use transforming our health and wellbeing.
The Baillie Gifford Mutual Funds are distributed by Baillie Gifford Funds Services LLC. Investors should carefully consider the objectives, risks, charges and expenses of the Funds before investing. This information and other information about the Funds can be found in the prospectus and the summary prospectus. For a prospectus and summary prospectus please go here. Please carefully read the Fund’s prospectus and related documents before investing.